| ||
| ||
Sun Pharmaceutical shares gain on US nod for cancer drug 'Doxil' Indian Express Sun Pharmaceutical Industries Ltd shares rose as much as 4.5 percent after the U.S. Food and Drug Administration approved its generic version of ovarian cancer drug Doxil made by Johnson & Johnson in the U.S. market. * "Doxil generic approval came in ... See all stories on this topic » | ||
Prime Minister Inaugurates Pharmaceutical Plant AllAfrica.com Ethiopia: Prime Minister Inaugurates Pharmaceutical Plant. 6 February 2013. Prime Minister Hailemariam inaugurated the pharmaceutical plant for the UAE's company pharmaceutical giant Julphar' today (February 6th) here in the Gerji area of Addis Ababa. See all stories on this topic » | ||
Teva Pharmaceutical Earnings: An Early Look Motley Fool Earnings season is in full swing, with huge numbers of companies having already given their latest numbers to investors. The key to making smart investment decisions with stocks releasing their quarterly reports is to anticipate how they'll do before ... See all stories on this topic » | ||
Schott Pharmaceutical Systems to participate in Pharmapack Europe 2013 Packaging Europe Schott Pharmaceutical Systems, one of the world's leading suppliers of high-quality primary pharmaceutical packaging, will be exhibiting at Pharmapack Europe in Paris. From February 13-14, 2013, the main focus of SCHOTT's booth 383 will be on the ... See all stories on this topic » | ||
Senate to mull ban on "pay for delay" pharmaceutical deals Reuters WASHINGTON (Reuters) - Key Democratic and Republican senators reintroduced legislation on Tuesday that would make it illegal for brand-name pharmaceutical companies to pay generic drug makers to keep their cheaper medicines off the market. See all stories on this topic » | ||
Omni Bio Pharmaceutical Appoints Dr. Michael Kamarck as New Director Marketwire (press release) DENVER, CO--(Marketwire - Feb 6, 2013) - Omni Bio Pharmaceutical, Inc. ("Omni Bio") ( OTCBB : OMBP), a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT) for the treatment of a variety of ... See all stories on this topic » | ||
Sudan's Central Bank Makes US$80 Million Available to Pharmaceutical ... AllAfrica.com Khartoum — The governor of Sudan's Central Bank (CBoS) Mohamed Kheir Al-Zubair announced today that his institution will provide $80 million in hard currency to pharmaceutical companies amid big increases in drug prices. Salah Kambal, the chairman ... See all stories on this topic » | ||
Russian pharmaceutical market continues to attract foreign investors The Pharma Letter The Russian pharmaceutical market will continue to attract foreign investors in the coming years, due to steady growth rates, which are significantly higher than those in the Western markets, and the existence of the state program for the development ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment